NLRP3 inhibitors: Unleashing their therapeutic potential against inflammatory diseases
- 8 November 2023
- journal article
- review article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 218, 115915
Abstract
No abstract availableKeywords
Funding Information
- Council for Scientific and Industrial Research
- Anusandhan National Research Foundation
This publication has 184 references indexed in Scilit:
- Mitochondria: diversity in the regulation of the NLRP3 inflammasomeTrends in Molecular Medicine, 2015
- Emerging Principles Governing Signal Transduction by Pattern-Recognition Receptors: Table 1.Cold Spring Harbor Perspectives in Biology, 2014
- The Evolving Role of Chemical Synthesis in Antibacterial Drug DiscoveryAngewandte Chemie International Edition, 2014
- 3,4-Methylenedioxy-β-nitrostyrene Inhibits NLRP3 Inflammasome Activation by Blocking Assembly of the InflammasomeJournal of Biological Chemistry, 2014
- IRAK-1 bypasses priming and directly links TLRs to rapid NLRP3 inflammasome activationProceedings of the National Academy of Sciences, 2013
- K+ Efflux Is the Common Trigger of NLRP3 Inflammasome Activation by Bacterial Toxins and Particulate MatterImmunity, 2013
- The Adaptor MAVS Promotes NLRP3 Mitochondrial Localization and Inflammasome ActivationCell, 2013
- Epigenetic modifications by dietary phytochemicals: Implications for personalized nutritionPharmacology & Therapeutics, 2013
- Sodium Overload and Water Influx Activate the NALP3 InflammasomeJournal of Biological Chemistry, 2011
- NLRP3 inflammasome activation: the convergence of multiple signalling pathways on ROS production?Nature Reviews Immunology, 2010